Results 201 to 210 of about 68,914 (294)

The use of Sirolimus for an unresectable and refractory venous malformation: A case series. [PDF]

Radiol Case Rep
Carolino DK, Muramatsu K, Tani Y, Sugimoto H, Ueda M.   +4 more
europepmc   +1 more source

TWO-YEAR FOLLOW-UP OF THE PIVOTAL MULTICENTER TRIALS OF SIROLIMUS.

, 2000
Barry D. Kahan
openalex   +1 more source

Treatment of Eosinophilic Fasciitis With Sirolimus [PDF]

JAMA Dermatology, 2016
Jenny E. Murase, Vikash S. Oza, Jeffrey P. North, Timothy G. Berger, Rabina Walsh   +4 more
openaire   +3 more sources

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Comparative Vascular Effects of Sirolimus and Everolimus on Isolated Human Saphenous Veins. [PDF]

Life (Basel)
Kaleli Durman D, Civelek E, Alp Yildirim Fİ, Teskin Ö, Uydeş Doğan BS.   +4 more
europepmc   +1 more source

IS CYCLOSPORINE-SIROLIMUS COMBINATION ACTUALLY ASSOCIATED WITH RENAL IMPAIRMENT IN KIDNEY TRANSPLANT RECIPIENTS?

, 2000
Kamran Mahalati, Barry D. Kahan
openalex   +1 more source

Liver transplantation using sirolimus and minimal corticosteroids(3-day taper) [PDF]

, 2001
James F. Trotter, Michael Wachs, Thomas H. Bak, T Trouillot, Nancy M. Stolpman, Gregory T. Everson, Igal Kam   +6 more
openalex   +1 more source

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

EVALUATION OF A DOSING ALGORITHM TO ADJUST SIROLIMUS TROUGH LEVELS IN RENAL TRANSPLANT RECIPIENTS.

, 2000
D W Holt, C Brattström, J. T. Burke, Joseph Zimmerman   +3 more
openalex   +1 more source

Role of hepatocellular senescence in the development of hepatocellular carcinoma and the potential for therapeutic manipulation. [PDF]

Hum Cell
Wijayasiri P, Astbury S, Needham G, Kaye P, Bhat M, Piccinini AM, Aravinthan AD.   +6 more
europepmc   +1 more source